Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

LEL

Lilly(Eli) (LEL)

Lilly(Eli)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:LEL
FechaHoraFuenteTítuloSímboloCompañía
30/01/201408:27PR Newswire (US)LILLY (ELI) & COMPANY - 4th Quarter EarningsLSE:LELLilly(Eli)
25/07/201301:00PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
08/07/201309:17PR Newswire (US)LILLY (ELI) & COMPANY - Form 8-KLSE:LELLilly(Eli)
08/05/201309:06PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8K FilingLSE:LELLilly(Eli)
07/05/201309:22PR Newswire (US)LILLY (ELI) & COMPANY - CEO Lechleiter to undergo surgeryLSE:LELLilly(Eli)
03/05/201301:00PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
03/05/201301:00PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
24/04/201310:31PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingLSE:LELLilly(Eli)
28/03/201308:35UK RegulatoryLilly (Eli) & Co Cancellation of ListingLSE:LELLilly(Eli)
28/03/201308:35PR Newswire (US)LILLY (ELI) & COMPANY - Cancellation of ListingLSE:LELLilly(Eli)
28/03/201303:00UK RegulatoryOfficial List Cancellation Lilly (Eli) & CompanyLSE:LELLilly(Eli)
26/03/201311:00PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing of SharesLSE:LELLilly(Eli)
27/02/201311:06PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel ListingLSE:LELLilly(Eli)
07/02/201307:59PR Newswire (US)LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for TabalumabLSE:LELLilly(Eli)
29/01/201307:33PR Newswire (US)LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 ResultsLSE:LELLilly(Eli)
24/01/201312:24PR Newswire (US)LILLY (ELI) & COMPANY - Miscellaneous - Other SEC FilingsLSE:LELLilly(Eli)
24/01/201312:22PR Newswire (US)LILLY (ELI) & COMPANY - Holding(s) in CompanyLSE:LELLilly(Eli)
24/01/201312:21PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingsLSE:LELLilly(Eli)
24/01/201312:19PR Newswire (US)LILLY (ELI) & COMPANY - Director/PDMR ShareholdingLSE:LELLilly(Eli)
24/01/201312:16PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementLSE:LELLilly(Eli)
24/01/201312:15PR Newswire (US)LILLY (ELI) & COMPANY - 3rd Quarter ResultsLSE:LELLilly(Eli)
24/01/201312:11PR Newswire (US)LILLY (ELI) & COMPANY - Annual Financial ReportLSE:LELLilly(Eli)
24/01/201312:02PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2012LSE:LELLilly(Eli)
24/01/201311:39PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2011LSE:LELLilly(Eli)
24/01/201311:37PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2010LSE:LELLilly(Eli)
16/01/201301:00PR Newswire (US)LILLY (ELI) & COMPANY - Amyvid Approved in European UnionLSE:LELLilly(Eli)
07/01/201308:11PR Newswire (US)LILLY (ELI) & COMPANY - Phase III data results for empagliflozinLSE:LELLilly(Eli)
07/01/201308:06PR Newswire (US)LILLY (ELI) & COMPANY - Additional Phase III Clinical TrialsLSE:LELLilly(Eli)
04/01/201306:55PR Newswire (US)LILLY (ELI) & COMPANY - 2012 Financial Guidance;2013 Financial GuidanceLSE:LELLilly(Eli)
20/12/201212:10PR Newswire (US)LILLY (ELI) & COMPANY - SEC Settlement Press ReleaseLSE:LELLilly(Eli)
 Showing the most relevant articles for your search:LSE:LEL